Shares of Arena Pharmaceuticals fell 3.24% to $75.91 at 14:36 EST on Tuesday, after five consecutive sessions in a row of gains. NASDAQ Composite is dropping 0.43% to $12,844.16, after two successive sessions in a row of gains. This seems, at the moment, a somewhat rough trend exchanging session today.

Arena Pharmaceuticals’s last close was $78.45, 18.81% under its 52-week high of $90.19.

Arena Pharmaceuticals’s Sales

Arena Pharmaceuticals’s sales growth is a negative 81.3% for the present quarter and 155.7% for the next. The company’s growth estimates for the current quarter is a negative 4.5% and positive 4.5% for the next.

Arena Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 98.5%, now sitting on 3.28M for the twelve trailing months.

Volatility

Arena Pharmaceuticals’s last day, last week, and last month’s average volatility was 0.47%, 1.62%, and 0.87%, respectively.

Arena Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 2.07%, 3.59%, and 3.20%, respectively.

Arena Pharmaceuticals’s Stock Yearly Top and Bottom Value

Arena Pharmaceuticals’s stock is valued at $75.91 at 14:36 EST, way under its 52-week high of $90.19 and way higher than its 52-week low of $32.95.

Arena Pharmaceuticals’s Moving Average

Arena Pharmaceuticals’s value is above its 50-day moving average of $69.42 and higher than its 200-day moving average of $70.02.

LEAVE A REPLY

Please enter your comment!
Please enter your name here